Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saffron in Patients With Ulcerative Colitis
NCT05117749Phase 2Unknown
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2023
- Primary completion
- Feb 2025
01
Overview
Phase 2, randomised, double-blind trial (6 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Changes in clinical response at 8 weeks, Changes in the fecal calprotectin level at 8 weeks and 2 more. Status: unknown.
Beyond the preview
Go deeper on NCT05117749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05117749.